This Biotech Uses Messenger RNA to Treat Lethal Lung Inflammation
Based close to Berlin, Germany, the biotech startup Pantherna Therapeutics is developing a messenger RNA…
02/08/2019 - 4 minutes
Germany
Wellington Partners Raises €210M to Invest in European Life Sciences
VC firm Wellington Partners has raised its fifth fund dedicated to investing in life science…
31/07/2019 - 3 minutes
German Biotech Breath Therapeutics Acquired in Deal Worth up to €500M
The Italian company Zambon has acquired the German biotech Breath Therapeutics for up to €500M,…
25/07/2019 - 2 minutes
Boehringer Ingelheim Acquires Cancer Vaccine Biotech in €325M Deal
The German giant Boehringer Ingelheim has acquired the Swiss company AMAL Therapeutics and its cancer…
16/07/2019 - 2 minutes
2019 Will Be a “Year of Realism” for Biotech Investments
Biotech investors regularly jump on new crazes, including the microbiome and CRISPR-Cas9 gene editing. At…
06/05/2019 - 6 minutes
Cosmetics Giant Acquires German Biotech’s Spider Silk Cosmetics Arm
The Swiss Givaudan, one of the largest cosmetics, flavors and fragrances companies in the world,…
30/04/2019 - 3 minutes
This Biotech Wants You to Age Well
Age is a risk factor in many diseases, such as cancer and heart disease. The…
15/03/2019 - 4 minutes
Flu Resistant to Antivirals? This Biotech Has a Drug for That
We are visiting the medieval German city of Tübingen this week. It hosts the biotech…
08/03/2019 - 3 minutes
Tuberculosis Treatment Kills Bacteria with Their Own Suicide Toxin
A European academic research collaboration has found a new potential weapon against antibiotic-resistant tuberculosis: its…
18/02/2019 - 3 minutes
Update: US District Court Rules Against MorphoSys’ Cancer Immunotherapy Patents
Update (01/02/2019): MorphoSys has agreed to end its long-running legal battle with Genmab and Janssen, after…
28/01/2019 - 3 minutes
Series C Bags German Company €17M for Irregular Heartbeat Treatment
Omeicos Therapeutics has secured €17M in a Series C round to fund clinical development of…
05/11/2018 - 2 minutes
Cancer Immunotherapy Phase I on Hold After Patient Death
The German biotech Affimed has halted two Phase I trials of its cancer immunotherapy after…
10/10/2018 - 2 minutes
